The latest cancer drugs news
Browsing: Cancer Drug News
European Commission approval for azacitidine tablets as frontline oral maintenance therapy for adults with acute myeloid leukaemia
Bristol Myers Squibb announced that the European Commission (EC) has granted full marketing authorisation for…
New research uncovers how cancers with common mutation develop resistance to targeted drugs
A new study by Dana-Farber Cancer Institute researchers has given scientists their first look at…
Potential drug target for difficult-to-treat breast cancer: RNA-binding proteins
In cancer research, it’s a common goal to find something about cancer cells — some…
WEHI and Boehringer Ingelheim partner to develop innovative cancer drugs
WEHI has partnered with Boehringer Ingelheim in a collaboration to discover and develop anti-cancer therapeutics…
Researchers discover a novel class of drugs that may help treat a deadly type of lymphoma
A new class of drugs that inhibits a “master switch” involved in the vast majority…
Overcoming a newly recognised form of resistance to modern prostate cancer drugs
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used…
How pancreatic cancer cells dodge drug treatments
Cancer cells can become resistant to treatments through adaptation, making them notoriously tricky to defeat…
Genetic study of liver cancer reveals new drug target
Drugs targeting the gene MAGEA3 may help block the growth of hepatocellular carcinoma (HCC), the…
NICE approves first immunotherapy combination for advanced bowel cancer patients with rare MSI-H/dMMR mutation
Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence…
Toward the first drug to treat a rare, lethal liver cancer
Treatment options for a deadly liver cancer, fibrolamellar carcinoma, are severely lacking. Drugs that work…